Christopher Wells

6.1k total citations
42 papers, 3.0k citations indexed

About

Christopher Wells is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Christopher Wells has authored 42 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 13 papers in Surgery and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Christopher Wells's work include Protein Degradation and Inhibitors (8 papers), Esophageal and GI Pathology (8 papers) and Multiple Myeloma Research and Treatments (5 papers). Christopher Wells is often cited by papers focused on Protein Degradation and Inhibitors (8 papers), Esophageal and GI Pathology (8 papers) and Multiple Myeloma Research and Treatments (5 papers). Christopher Wells collaborates with scholars based in United States, United Kingdom and Germany. Christopher Wells's co-authors include Stefan Knapp, Susanne Müller, O. Fedorov, P. Filippakopoulos, S. Picaud, Sarah Martin, Paul E. Brennan, Martin Philpott, Ananya Das and Cuong C. Nguyen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Circulation.

In The Last Decade

Christopher Wells

41 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Wells United States 23 1.3k 652 588 520 418 42 3.0k
Klaus Wagner Germany 33 708 0.6× 461 0.7× 465 0.8× 462 0.9× 266 0.6× 68 3.0k
Toshihiko Ishida Japan 35 1.3k 1.0× 656 1.0× 993 1.7× 204 0.4× 527 1.3× 220 3.9k
Anna Eriksson Sweden 22 1.7k 1.4× 267 0.4× 395 0.7× 325 0.6× 371 0.9× 48 3.6k
Lennart Friis‐Hansen Denmark 35 1.8k 1.4× 709 1.1× 1.1k 1.8× 161 0.3× 408 1.0× 149 4.6k
Tom Pettersson Finland 28 909 0.7× 508 0.8× 327 0.6× 392 0.8× 227 0.5× 107 2.5k
Alois Lang Austria 27 899 0.7× 308 0.5× 557 0.9× 688 1.3× 196 0.5× 104 3.2k
Antonella Afeltra Italy 36 564 0.4× 431 0.7× 510 0.9× 356 0.7× 273 0.7× 196 4.3k
Chang‐Keun Lee South Korea 29 574 0.5× 479 0.7× 285 0.5× 237 0.5× 169 0.4× 175 2.7k
Birgit Sawitzki Germany 37 1.0k 0.8× 162 0.2× 855 1.5× 543 1.0× 352 0.8× 128 5.2k
Byron P. Croker United States 41 1.3k 1.0× 427 0.7× 566 1.0× 144 0.3× 433 1.0× 100 5.3k

Countries citing papers authored by Christopher Wells

Since Specialization
Citations

This map shows the geographic impact of Christopher Wells's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Wells with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Wells more than expected).

Fields of papers citing papers by Christopher Wells

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Wells. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Wells. The network helps show where Christopher Wells may publish in the future.

Co-authorship network of co-authors of Christopher Wells

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Wells. A scholar is included among the top collaborators of Christopher Wells based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Wells. Christopher Wells is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wells, Christopher & Alistair Elfick. (2023). Transfection reflections: fit-for-purpose delivery of nucleic acids. Nature Reviews Molecular Cell Biology. 24(11). 771–772. 4 indexed citations
3.
Lalanne, Jean‐Benoît, Christopher Wells, Gene‐Wei Li, et al.. (2020). Alternative transcription cycle for bacterial RNA polymerase. Nature Communications. 11(1). 448–448. 29 indexed citations
4.
Eccleston, Christopher, Bart Morlion, & Christopher Wells. (2018). Pain in Europe. Oxford University Press eBooks. 2 indexed citations
5.
Hammitzsch, Ariane, C. Tallant, O. Fedorov, et al.. (2015). CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses. Proceedings of the National Academy of Sciences. 112(34). 10768–10773. 195 indexed citations
6.
Philpott, Martin, Catherine Rogers, Clarence Yapp, et al.. (2014). Assessing cellular efficacy of bromodomain inhibitors using fluorescence recovery after photobleaching. Epigenetics & Chromatin. 7(1). 14–14. 49 indexed citations
7.
Ciceri, Pietro, Susanne Müller, Alison O’Mahony, et al.. (2014). Dual kinase-bromodomain inhibitors for rationally designed polypharmacology. Nature Chemical Biology. 10(4). 305–312. 261 indexed citations
8.
Hardy, Timothy, Christopher Wells, Stuart Kendrick, et al.. (2013). White cell count and platelet count associate with histological alcoholic hepatitis in jaundiced harmful drinkers. BMC Gastroenterology. 13(1). 55–55. 25 indexed citations
9.
Dworkin, Robert H., Alec O'connor, Joel L. Kent, et al.. (2013). Interventional management of neuropathic pain: NeuPSIG recommendations. Pain. 154(11). 2249–2261. 332 indexed citations
10.
Wells, Christopher, et al.. (2012). LKB1 tumor suppressor regulates AMP kinase/mTOR-independent cell growth and proliferation via the phosphorylation of Yap. Oncogene. 32(35). 4100–4109. 63 indexed citations
11.
Haanpää, Maija, Geoffrey K. Gourlay, Joel L. Kent, et al.. (2010). Treatment Considerations for Patients With Neuropathic Pain and Other Medical Comorbidities. Mayo Clinic Proceedings. 85(3). S15–S25. 67 indexed citations
12.
Das, Ananya, et al.. (2009). An economic analysis of endoscopic ablative therapy for management of nondysplastic Barrett’s esophagus. Endoscopy. 41(5). 400–408. 39 indexed citations
13.
Dowson, Andrew, Michael Mullen, Arif Anis Khan, et al.. (2009). Response to Letter Regarding Article, “Migraine Intervention With STARFlex Technology (MIST) Trial”. Circulation. 119(5).
14.
Dowson, Andrew, Michael Mullen, Richard Peatfield, et al.. (2008). Migraine Intervention With STARFlex Technology (MIST) Trial. Circulation. 117(11). 1397–1404. 377 indexed citations
15.
Das, Ananya, Christopher Wells, & Cuong C. Nguyen. (2008). Incidental Cystic Neoplasms of Pancreas: What Is the Optimal Interval of Imaging Surveillance. The American Journal of Gastroenterology. 103(7). 1657–1662. 64 indexed citations
16.
Orrego, Mauricio, Hugo E. Vargas, Vijayan Balan, et al.. (2006). Portal Hypertension Due to a Splenic Arteriovenous Fistula: A Case Report. Digestive Diseases and Sciences. 51(6). 1113–1116. 14 indexed citations
17.
18.
Wells, Christopher, et al.. (2006). Bezoar Formation Requiring Endoscopic Removal After Intentional Overdose of Extended‐Release Nifedipine. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 26(12). 1802–1805. 17 indexed citations
19.
Wells, Christopher, Vijayan Balan, & Jerry D. Smilack. (2005). Pyogenic Liver Abscess After Colonoscopy in a Patient With Ulcerative Colitis. Clinical Gastroenterology and Hepatology. 3(12). A24–A24. 21 indexed citations
20.
Wells, Christopher & Miguel R. Arguedas. (2004). Amebic Liver Abscess. Southern Medical Journal. 97(7). 673–682. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026